Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-16

FDA Approved: PURELAX — Supplemental Application (CVS Pharmacy)

View source ↗

Summary

The FDA approved a supplemental application for PureLax (polyethylene glycol 3350) submitted by CVS Pharmacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PURELAX (POLYETHYLENE GLYCOL 3350)

Snippet

SUPPL AP for PURELAX (POLYETHYLENE GLYCOL 3350)